T-cell epitope vaccine design by immunoinformatics

Vaccination is generally considered to be the most effective method of preventing infectious diseases. All vaccinations work by presenting a foreign antigen to the immune system in order to evoke an immune response. The active agent of a vaccine may be intact but inactivated (‘attenuated’) forms of the causative pathogens (bacteria or viruses), or purified components of the pathogen that have been found to be highly immunogenic. The increased understanding of antigen recognition at molecular level has resulted in the development of rationally designed peptide vaccines. The concept of peptide vaccines is based on identification and chemical synthesis of B-cell and T-cell epitopes which are immunodominant and can induce specific immune responses. The accelerating growth of bioinformatics techniques and applications along with the substantial amount of experimental data has given rise to a new field, called immunoinformatics. Immunoinformatics is a branch of bioinformatics dealing with in silico analysis and modelling of immunological data and problems. Different sequence- and structure-based immunoinformatics methods are reviewed in the paper.

[1]  Taku Suto,et al.  An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries , 2000, Immunogenetics.

[2]  E. Pålsson-McDermott,et al.  Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4 , 2004, Immunology.

[3]  Shoba Ranganathan,et al.  Modeling the structure of bound peptide ligands to major histocompatibility complex , 2004, Protein science : a publication of the Protein Society.

[4]  P. Petrone,et al.  MHC-peptide binding is assisted by bound water molecules. , 2004, Journal of molecular biology.

[5]  L. Baum,et al.  A Maximization Technique Occurring in the Statistical Analysis of Probabilistic Functions of Markov Chains , 1970 .

[6]  Qi Liu,et al.  A HMM-based method to predict the transmembrane regions of \beta-barrel membrane proteins , 2003, Comput. Biol. Chem..

[7]  A Sette,et al.  A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets. , 1997, Human immunology.

[8]  M. Mahler,et al.  Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. , 2003, Clinical immunology.

[9]  Pingping Guan,et al.  EpiJen: a server for multistep T cell epitope prediction , 2006, BMC Bioinformatics.

[10]  P. Coveney,et al.  Molecular Basis of Peptide Recognition by the TCR: Affinity Differences Calculated Using Large Scale Computing1 , 2005, The Journal of Immunology.

[11]  Biing-Hwang Juang,et al.  Hidden Markov Models for Speech Recognition , 1991 .

[12]  J. Fagerberg,et al.  T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma. , 2003, Blood.

[13]  C. Del Carpio,et al.  A combined bioinformatic approach oriented to the analysis and design of peptides with high affinity to MHC class I molecules , 2002, Immunology and cell biology.

[14]  P. Butler,et al.  Assembly of a spherical plant virus. , 1976, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[15]  J. Drijfhout,et al.  A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. , 1995, Human immunology.

[16]  Søren Buus,et al.  Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.

[17]  E. Celis,et al.  Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. , 2000, Cancer research.

[18]  W. Szmuness,et al.  The immune response of healthy adults to a reduced dose of hepatitis B vaccine , 1981, Journal of medical virology.

[19]  Irini Doytchinova,et al.  The HLA-A2-supermotif: a QSAR definition. , 2003, Organic & biomolecular chemistry.

[20]  Hiroyuki Honda,et al.  Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma , 2004, BMC Bioinformatics.

[21]  B. Walker,et al.  HIV versus the immune system: another apparent victory for the virus. , 2001, The Journal of clinical investigation.

[22]  Didier Rognan,et al.  Recovery of known T-cell epitopes by computational scanning of a viral genome , 2002, J. Comput. Aided Mol. Des..

[23]  J. Pipas,et al.  Chaperone-mediated in vitro assembly of Polyomavirus capsids , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Alex Bateman,et al.  HMM-based databases in InterPro , 2002, Briefings Bioinform..

[25]  D. Wiley,et al.  Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R W Chesnut,et al.  Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.

[27]  Jian Huang,et al.  CED: a conformational epitope database , 2006, BMC Immunology.

[28]  K. Asadpour‐Zeynali,et al.  Modeling drug solubility in water-cosolvent mixtures using an artificial neural network. , 2004, Farmaco.

[29]  Miles P. Davenport,et al.  An empirical method for the prediction of T-cell epitopes , 2004, Immunogenetics.

[30]  N. Petrovsky,et al.  Immunoinformatics and its relevance to understanding human immune disease , 2005, Expert review of clinical immunology.

[31]  Manoj Bhasin,et al.  Analysis and prediction of affinity of TAP binding peptides using cascade SVM , 2004, Protein science : a publication of the Protein Society.

[32]  Atsushi Imiya,et al.  Machine Learning and Data Mining in Pattern Recognition , 2013, Lecture Notes in Computer Science.

[33]  U. Şahin,et al.  Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.

[34]  R. Meloen,et al.  Synthetic peptide vaccines: unexpected fulfillment of discarded hope? , 2001, Biologicals : journal of the International Association of Biological Standardization.

[35]  Richard G. Jenner,et al.  Viral bioinformatics: computational views of host and pathogen. , 2003, Novartis Foundation symposium.

[36]  Nebojsa Jojic,et al.  Efficient approximations for learning phylogenetic HMM models from data , 2004, ISMB/ECCB.

[37]  C. Jacob,et al.  Priming immunization against cholera toxin and E. coli heat‐labile toxin by a cholera toxin short peptide‐beta‐galactosidase hybrid synthesized in E. coli. , 1985, The EMBO journal.

[38]  D. Rognan,et al.  Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein. , 1995, Acta crystallographica. Section D, Biological crystallography.

[39]  Chee Keong Kwoh,et al.  PREDTAP: a system for prediction of peptide binding to the human transporter associated with antigen processing , 2006, Immunome research.

[40]  Channa K. Hattotuwagama,et al.  Integrating In Silico and In Vitro Analysis of Peptide Binding Affinity to HLA-Cw*0102: A Bioinformatic Approach to the Prediction of New Epitopes , 2009, PloS one.

[41]  Ruben Abagyan,et al.  Prediction of the binding energy for small molecules, peptides and proteins , 1999, Journal of molecular recognition : JMR.

[42]  Victor Ciesielski,et al.  Application of Genetic Search in Derivation of Matrix Models of Peptide Binding to MHC Molecules , 1997, ISMB.

[43]  W. W. Nichols,et al.  Plasmid DNA Vaccines: Tissue Distribution and Effects of DNA Sequence, Adjuvants and Delivery Method on Integration into Host DNA , 2001, Intervirology.

[44]  Naoki Abe,et al.  Prediction of MHC Class I Binding Peptides by a Query Learning Algorithm Based on Hidden Markov Models , 2002, Journal of biological physics.

[45]  C. Bridges,et al.  Seasonal influenza vaccines. , 2009, Current topics in microbiology and immunology.

[46]  K. Timmis,et al.  Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium , 1997, Cell.

[47]  C A Floudas,et al.  A predictive method for the evaluation of peptide binding in pocket 1 of HLA‐DRB1 via global minimization of energy interactions , 1997, Proteins.

[48]  S. Smith The polyepitope approach to DNA vaccination. , 1999, Current opinion in molecular therapeutics.

[49]  D. Rognan,et al.  Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. , 1999, Journal of medicinal chemistry.

[50]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[51]  Pierre Baldi,et al.  COBEpro: a novel system for predicting continuous B-cell epitopes. , 2009, Protein engineering, design & selection : PEDS.

[52]  Irini A. Doytchinova,et al.  EpiTOP - a proteochemometric tool for MHC class II binding prediction , 2010, Bioinform..

[53]  P. Travers,et al.  The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. , 1998, Journal of immunology.

[54]  J. Rothbard,et al.  Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. , 1994, Journal of immunology.

[55]  Stefan Kienle,et al.  Tolerance to Amino Acid Variations in Peptides Binding to the Major Histocompatibility Complex Class I Protein H-2Kb(*) , 1995, The Journal of Biological Chemistry.

[56]  O. Schueler‐Furman,et al.  Structure‐based prediction of binding peptides to MHC class I molecules: Application to a broad range of MHC alleles , 2000, Protein science : a publication of the Protein Society.

[57]  D Rognan,et al.  Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. , 1994, Biochemistry.

[58]  C. Montesano,et al.  Computer-Based Design of an HLA-Haplotype and HIV-Clade Independent Cytotoxic T-Lymphocyte (CTL) Assay for Monitoring HIV-Specific Immunity , 2002, Molecular medicine.

[59]  O. Lund,et al.  An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.

[60]  M. Delorenzi,et al.  An HMM model for coiled-coil domains and a comparison with PSSM-based predictions , 2002, Bioinform..

[61]  W. W. Nichols,et al.  Plasmid DNA vaccines: assay for integration into host genomic DNA. , 2000, Developments in biologicals.

[62]  Darren R Flower,et al.  Coupling In Silico and In Vitro Analysis of Peptide-MHC Binding: A Bioinformatic Approach Enabling Prediction of Superbinding Peptides and Anchorless Epitopes , 2004, The Journal of Immunology.

[63]  H. Margalit,et al.  Insights from MHC-bound peptides. , 2003, Novartis Foundation symposium.

[64]  Matteo Bellone,et al.  Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 , 1999, The Journal of experimental medicine.

[65]  E. Pamer,et al.  Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.

[66]  L Raddrizzani,et al.  In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program1 , 2000, The Journal of Immunology.

[67]  Meena Kishore Sakharkar,et al.  Types of inter-atomic interactions at the MHC-peptide interface: Identifying commonality from accumulated data , 2002, BMC Structural Biology.

[68]  T. Lundstedt,et al.  Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.

[69]  Claude Beazley,et al.  A Novel Predictive Technique for the MHC Class II Peptide-Binding Interaction , 2003, Molecular medicine.

[70]  C. Janeway Immunobiology: The Immune System in Health and Disease , 1996 .

[71]  Irini A. Doytchinova,et al.  Towards the chemometric dissection of peptide – HLA-A*0201 binding affinity: comparison of local and global QSAR models , 2005, J. Comput. Aided Mol. Des..

[72]  S. Tenzer,et al.  Using the World Wide Web for predicting CTL epitopes. , 2003, Current opinion in immunology.

[73]  H. Rammensee,et al.  Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2. , 2003, Cancer immunity.

[74]  Gajendra P. S. Raghava,et al.  ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..

[75]  Vladimir Brusic,et al.  Prediction of promiscuous peptides that bind HLA class I molecules , 2002, Immunology and cell biology.

[76]  A. Sette,et al.  T-lymphocyte epitope identification and their use in vaccine development for HIV-1. , 2002, Frontiers in bioscience : a journal and virtual library.

[77]  Lawrence R. Rabiner,et al.  A tutorial on hidden Markov models and selected applications in speech recognition , 1989, Proc. IEEE.

[78]  M. Cheever,et al.  Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  I. Hellstrom,et al.  Novel approaches to therapeutic cancer vaccines , 2003, Expert review of vaccines.

[80]  S. Vajda,et al.  Protein-protein docking: is the glass half-full or half-empty? , 2004, Trends in biotechnology.

[81]  P. Mortimer Can postexposure vaccination against smallpox succeed? , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  Yingdong Zhao,et al.  T-Cell Epitope Prediction with Combinatorial Peptide Libraries , 2003, J. Comput. Biol..

[83]  H. Rammensee,et al.  Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes , 2004, Cancer Immunology, Immunotherapy.

[84]  Fang-Xiang Wu,et al.  Optimally-connected Hidden Markov Models for Predicting Mhc-binding Peptides , 2006, J. Bioinform. Comput. Biol..

[85]  M. Bishop,et al.  Maximum likelihood alignment of DNA sequences. , 1986, Journal of molecular biology.

[86]  Morten Nielsen,et al.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..

[87]  Thomas Jackson,et al.  Neural Computing - An Introduction , 1990 .

[88]  H. Rammensee,et al.  The making of the dominant MHC class I ligand SYFPEITHI , 1998, European journal of immunology.

[89]  A. Alix,et al.  Predictive estimation of protein linear epitopes by using the program PEOPLE. , 1999, Vaccine.

[90]  Rajat K De,et al.  Immunoinformatics: an integrated scenario , 2010, Immunology.

[91]  Jun Zeng,et al.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach , 2001, J. Comput. Aided Mol. Des..

[92]  A. D. De Groot,et al.  Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. , 1998, Vaccine.

[93]  Wen Liu,et al.  Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models , 2006, BMC Bioinformatics.

[94]  Michael A. Gonzalez,et al.  From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.

[95]  Ulrike Alexiev,et al.  Differential Peptide Dynamics Is Linked to Major Histocompatibility Complex Polymorphism* , 2004, Journal of Biological Chemistry.

[96]  J. Fagerberg,et al.  Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA , 2004, Cancer Immunology, Immunotherapy.

[97]  Pingping Guan,et al.  MHCPred: a server for quantitative prediction of peptide-MHC binding , 2003, Nucleic Acids Res..

[98]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[99]  Eugene I Shakhnovich,et al.  Structural mining: self-consistent design on flexible protein-peptide docking and transferable binding affinity potential. , 2004, Journal of the American Chemical Society.

[100]  Søren Brunak,et al.  Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach , 2004, Bioinform..

[101]  S Vajda,et al.  Toward computational determination of peptide‐receptor structure , 1993, Protein science : a publication of the Protein Society.

[102]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[103]  A. Suhrbier,et al.  Prediction of an HLA B8-restricted influenza epitope by motif. , 1993, Immunology.

[104]  Thorsten Joachims,et al.  Making large-scale support vector machine learning practical , 1999 .

[105]  B. Schölkopf,et al.  Advances in kernel methods: support vector learning , 1999 .

[106]  Ettore Appella,et al.  A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. , 2003, Immunity.

[107]  Theodore V. Tselios,et al.  NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations. , 2004, European journal of biochemistry.

[108]  H. Margalit,et al.  Sequence features that correlate with MHC restriction. , 1994, Molecular immunology.

[109]  J. Berzofsky,et al.  Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. , 1995, Vaccine.

[110]  Ali Azizi,et al.  Innovative bioinformatic approaches for developing peptide‐based vaccines against hypervariable viruses , 2011, Immunology and cell biology.

[111]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques with Java implementations , 2002, SGMD.

[112]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[113]  H. Volk,et al.  Random Screening of Proteins for HLA-A*0201-Binding Nine-Amino Acid Peptides Is Not Sufficient for Identifying CD8 T Cell Epitopes Recognized in the Context of HLA-A*02011 , 2004, The Journal of Immunology.

[114]  Loris Nanni,et al.  Machine learning algorithms for T-cell epitopes prediction , 2006, Neurocomputing.

[115]  Mark M. Davis,et al.  Two-step binding mechanism for T-cell receptor recognition of peptide–MHC , 2002, Nature.

[116]  Clemencia Pinilla,et al.  A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. , 2004, Molecular immunology.

[117]  E. Reinherz,et al.  Prediction of MHC class I binding peptides using profile motifs. , 2002, Human immunology.

[118]  Robert H Levis,et al.  Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[119]  N. Brewer,et al.  Evaluating the impact of human papillomavirus vaccines. , 2009, Vaccine.

[120]  A Sette,et al.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.

[121]  Simon Cawley,et al.  HMM sampling and applications to gene finding and alternative splicing , 2003, ECCB.

[122]  H. Sbai,et al.  Use of T cell epitopes for vaccine development. , 2001, Current drug targets. Infectious disorders.

[123]  P. Kloetzel,et al.  MAPPP: MHC class I antigenic peptide processing prediction. , 2003, Applied bioinformatics.

[124]  Olivier Michielin,et al.  Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. , 2002, Journal of molecular biology.

[125]  H. Kalbacher,et al.  New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library. , 1996, European journal of biochemistry.

[126]  Piero Fariselli,et al.  A sequence-profile-based HMM for predicting and discriminating beta barrel membrane proteins , 2002, ISMB.

[127]  S. Muta,et al.  Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217. , 2000, Biopolymers.

[128]  H Mamitsuka,et al.  Predicting peptides that bind to MHC molecules using supervised learning of hidden markov models , 1998, Proteins.

[129]  S Vajda,et al.  Flexible docking of peptides to class I major-histocompatibility-complex receptors. , 1995, Genetic analysis : biomolecular engineering.

[130]  P. Stern,et al.  Vaccine and antibody-directed T cell tumour immunotherapy. , 2004, Biochimica et biophysica acta.

[131]  M. Colombo,et al.  Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. , 1998, Blood.

[132]  R. Sundaram,et al.  Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1. , 2008, The journal of peptide research : official journal of the American Peptide Society.

[133]  Chris H. Q. Ding,et al.  Multi-class protein fold recognition using support vector machines and neural networks , 2001, Bioinform..

[134]  H. Grey,et al.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[135]  A. Tarkowska,et al.  Prediction of left ventricular ejection fraction in patients with coronary artery disease based on an analysis of perfusion patterns at rest. Assessment by an artificial neural network. , 2004, Nuclear medicine review. Central & Eastern Europe.

[136]  Limsoon Wong,et al.  FIMM, a database of functional molecular immunology , 2000, Nucleic Acids Res..

[137]  D. Haussler,et al.  Hidden Markov models in computational biology. Applications to protein modeling. , 1993, Journal of molecular biology.

[138]  Richard A. Goldstein,et al.  Performance of an iterated T-HMM for homology detection , 2004, Bioinform..

[139]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[140]  K. Kim,et al.  Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling. , 1996, Molecular immunology.

[141]  Steven Salzberg,et al.  A Weighted Nearest Neighbor Algorithm for Learning with Symbolic Features , 2004, Machine Learning.

[142]  G. Jung,et al.  From combinatorial libraries to MHC ligand motifs, T-cell superagonists and antagonists. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[143]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[144]  M. Tommasino,et al.  Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.

[145]  I. Haworth,et al.  Water dynamics at the binding interface of four different HLA-A2-peptide complexes. , 2000, International immunology.

[146]  T. Lehner,et al.  Identification of T- and B-cell epitopes in synthetic peptides derived from a Streptococcus mutans protein and characterization of their antigenicity and immunogenicity. , 1990, Archives of oral biology.

[147]  R. Naz,et al.  Peptide vaccines against cancer, infectious diseases, and conception. , 2007, Frontiers in bioscience : a journal and virtual library.

[148]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[149]  C. DeLisi,et al.  Free energy mapping of class I MHC molecules and structural determination of bound peptides , 1996, Protein science : a publication of the Protein Society.

[150]  P. Pastoret,et al.  A brief history of vaccines and vaccination. , 2007, Revue scientifique et technique.

[151]  S. Nathenson,et al.  Methods to study peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.

[152]  Zhong Huang,et al.  Virus-like particles production in green plants. , 2006, Methods.

[153]  D. Klinman,et al.  DNA vaccines: safety and efficacy issues , 2004, Springer Seminars in Immunopathology.

[154]  S. Gurunathan,et al.  DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.

[155]  Gajendra P. S. Raghava,et al.  Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences , 2005, Nucleic Acids Res..

[156]  B. Baker,et al.  Thermodynamic and kinetic analysis of a peptide-class I MHC interaction highlights the noncovalent nature and conformational dynamics of the class I heterotrimer. , 2003, Biochemistry.

[157]  T. Liesegang Varicella zoster virus vaccines: effective, but concerns linger. , 2009, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[158]  L. Moreland MHC class II molecules , 2004 .

[159]  T. Hanai,et al.  Hidden Markov model-based prediction of antigenic peptides that interact with MHC class II molecules. , 2002, Journal of bioscience and bioengineering.

[160]  P. Barker,et al.  Efficient Generation of Major Histocompatibility Complex Class I-Peptide Complexes Using Synthetic Peptide Libraries* , 1998, The Journal of Biological Chemistry.

[161]  T. Elliott,et al.  Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. , 2000, Tissue antigens.

[162]  M H Lessof,et al.  Advances in immunology. , 1978, The Practitioner.

[163]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[164]  R Elber,et al.  Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. , 1998, Folding & design.

[165]  J L Cornette,et al.  Consistency in structural energetics of protein folding and peptide recognition , 1997, Protein science : a publication of the Protein Society.

[166]  Rajeev K. Azad,et al.  Probabilistic methods of identifying genes in prokaryotic genomes: Connections to the HMM theory , 2004, Briefings Bioinform..

[167]  S. Higgs,et al.  A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection , 2010, Nature Medicine.

[168]  D R Flower,et al.  MHC Class II Binding Prediction by Molecular Docking , 2011, Molecular informatics.

[169]  H. L. Hiew,et al.  MHC haplotype analysis by artificial neural networks. , 1998, Human immunology.

[170]  Ji Wan,et al.  SVRMHC prediction server for MHC-binding peptides , 2006, BMC Bioinformatics.

[171]  W. Szmuness,et al.  PASSIVE.ACTIVE IMMUNISATION AGAINST HEPATITIS B: IMMUNOGENICITY STUDIES IN ADULT AMERICANS , 1981, The Lancet.

[172]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[173]  B Honig,et al.  On the calculation of binding free energies using continuum methods: Application to MHC class I protein‐peptide interactions , 1997, Protein science : a publication of the Protein Society.

[174]  Sean R. Eddy,et al.  Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids , 1998 .

[175]  M. Bayer,et al.  Particles associated with Australia Antigen in the Sera of Patients with Leukaemia, Down's Syndrome and Hepatitis , 1968, Nature.

[176]  D. Rognan,et al.  Customized versus universal scoring functions: application to class I MHC-peptide binding free energy predictions. , 2001, Bioorganic & medicinal chemistry letters.

[177]  M. A. Liu,et al.  DNA vaccines: a review , 2003, Journal of internal medicine.

[178]  W. Hahn,et al.  The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. , 1999, Immunity.